The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients
Open Access
- 19 February 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (6), 1132-1134
- https://doi.org/10.1093/ndt/gfab047
Abstract
Vincenzo La Milia, Silvia Tonolo, Francesco Luzzaro, Claudio Bonato, Andrea Cavalli, Barbara Foglieni, Consuelo Debiase, Monica Limardo, Selena Longhi, Chiara RThis publication has 12 references indexed in Scilit:
- Humoral Immune Response to SARS-CoV-2 in IcelandThe New England Journal of Medicine, 2020
- Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance HemodialysisAmerican Journal of Kidney Diseases, 2020
- High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic ScreeningJournal of the American Society of Nephrology, 2020
- Epidemiology of COVID-19 in an Urban Dialysis CenterJournal of the American Society of Nephrology, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Serology assays to manage COVID-19Science, 2020
- COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, ItalyKidney International Reports, 2020
- Detection of antibodies against SARS‐CoV‐2 in patients with COVID‐19Journal of Medical Virology, 2020
- Targeting Immunity in End-Stage Renal DiseaseAmerican Journal of Nephrology, 2017